Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Butyrate supplements provide sodium butyrate, calcium butyrate, or magnesium butyrate, which are short-chain fatty acids that fuel colonocytes and strengthen intestinal barrier function. These postbiotic compounds activate GPR43 and GPR109A receptors to reduce inflammation and support gut-brain axis communication.
Reported Benefits (Provisional)
Origin & History
Butyrate is a short-chain fatty acid produced by the fermentation of dietary fibers in the colon. It can also be synthetically produced and is available in various salt forms such as sodium, calcium, and magnesium butyrate. These forms are created through chemical reactions involving butyric acid and the respective minerals.
Research Narrative (Provisional)
Butyrate has been studied extensively for its role in gut health, with numerous studies highlighting its anti-inflammatory and metabolic benefits. Some clinical trials have demonstrated its potential in managing inflammatory bowel diseases.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Butyrate (Sodium/Calcium/Magnesium) is a short-chain fatty acid (SCFA) salt supplement, not a whole food, so its nutritional profile is defined primarily by its bioactive compound and mineral counterions. Butyrate content: typically 300–600 mg of butyric acid per capsule/tablet in commercial supplements, delivering 4-carbon saturated fatty acid (C4:0). Mineral contributions vary by salt form: Sodium butyrate provides approximately 150–200 mg sodium per 500 mg dose; Calcium butyrate provides approximately 80–120 mg elemental calcium per 500 mg dose; Magnesium butyrate provides approximately 50–80 mg elemental magnesium per 500 mg dose. Caloric contribution is minimal, approximately 4 kcal/g of butyrate, with negligible protein, carbohydrate, or fiber content. No significant vitamins or additional micronutrients are present. Bioavailability notes: uncoated sodium butyrate is rapidly absorbed in the upper GI tract, limiting colonic delivery; microencapsulated or enteric-coated forms demonstrate significantly improved colonic bioavailability, reaching the distal colon where colonocytes preferentially metabolize butyrate as their primary energy substrate (estimated 70–90% of colonocyte energy derived from butyrate). Calcium and magnesium salt forms may offer slightly more sustained release due to lower solubility. Plasma butyrate concentrations following supplementation typically reach 0.5–2.0 mmol/L depending on dose and formulation.
Reported Mechanism (Provisional)
Butyrate activates G-protein coupled receptors GPR43, GPR109A, and GPR41 in colonic epithelial cells, triggering anti-inflammatory pathways and enhancing tight junction proteins like claudin-1 and occludin. It inhibits histone deacetylase (HDAC) activity, promoting regulatory T-cell differentiation and reducing NF-κB-mediated inflammatory cytokine production. Butyrate also crosses the blood-brain barrier to influence microglial activation and BDNF expression in the hippocampus.
Clinical Narrative (Provisional)
Human studies using 150-300mg daily sodium butyrate for 8-12 weeks show 20-30% improvements in intestinal permeability markers and reduced inflammatory cytokines IL-6 and TNF-α. A randomized controlled trial with 66 IBS patients demonstrated 40% reduction in abdominal pain scores with 300mg sodium butyrate daily. Limited clinical evidence exists for mental health benefits, with most data derived from animal studies and mechanistic research.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.